A
Atlas Oncology Partners
Value-based oncology care enablement and risk management platform
About Atlas Oncology Partners
Atlas Oncology Partners is a healthcare company that enables value-based oncology care by embedding interdisciplinary teams into community oncology practices and assuming full medical cost risk. The company was founded by the healthcare investment firm Rubicon Founders and officially launched in January 2026 in Memphis, Tennessee, with West Cancer Center & Research Institute as its first partner. The co-founders include President Kate Barnard Roberts, Chief Physician Executive Dr. David Johnson, and Chief of Staff Emma Nosseir.
The firm's business model is centered on partnering with oncologists and payers to improve patient outcomes and experiences while managing the total cost of cancer care. Atlas takes on full financial risk for a patient's medical expenses from payers, such as Medicare Advantage and Commercial plans, through outcomes-based contracts. This aligns financial incentives with the delivery of high-value care. The company then invests in the necessary infrastructure, technology, and clinical staff for its partner practices, insulating them from downside financial risk.
Atlas's service involves embedding a dedicated, local "Extended Care Team" within oncology practices. This team, managed by Atlas, includes providers, nurses, patient navigators, and social workers who deliver comprehensive wrap-around services. Key components of the Atlas care model include proactive care coordination, psychosocial support, 24/7 symptom management triage, management of cancer-adjacent conditions, and advanced supportive care to optimize quality of life. By providing same-day or next-day appointments and other resources, the model aims to reduce avoidable emergency room visits and hospitalizations. The platform unifies multiple data sources to provide actionable insights for providers and supportive care staff. In January 2026, Humana announced a partnership with Atlas to provide these coordinated services to its Medicare Advantage members in Tennessee and Mississippi.
In February 2026, Atlas Oncology Partners announced it had raised $28 million in a Series A funding round. The round was led by Flare Capital Partners with significant participation from Rubicon Founders. The capital is intended to fund geographic expansion with new oncology partners and further investment in clinical and operational infrastructure. The company plans to expand throughout the Southeast in 2026, targeting markets in Alabama, Arkansas, Louisiana, and Texas.
Source: Dealroom company dataNews
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Feb 2026 | $28M | $112M | Rubicon Founders · Flare Capital Partners | ↗ |
Growth signals
Latest recorded traffic for Atlas Oncology Partners is 980 monthly website visits, up 24.1% over the last three months.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
Clara M. Robinson Foundation, Inc.Population health management and holistic preventative care. |
Manchester, United States | Operational | 9 | — | — |
Alabama Cancer CareCommunity-based oncology and hematology care network. |
Northport, United States | Operational | |||
Coreo, Inc.AI-driven execution layer for oncology care management. |
— | Operational | |||
Indiora HealthSpecialist medical consultations and treatment coordination in India. |
New Delhi, India | Operational | |||
The Cancer CoachWorkplace vitality and cancer defense coaching programs. |
— | Operational | |||
INTERLINK Health ServicesManaged care solutions for complex medical procedures. |
Hillsboro, United States | Operational | |||
qlaroPersonalized guidance platform for cancer treatment journeys. |
— | Operational | |||
Danja Cancer CentreCoordinated, patient-centered, multidisciplinary oncology and palliative care. |
— | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Atlas Oncology Partners in the Nashville ecosystem
The Atlas Oncology Partners office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Flare Capital Partners
Rubicon Founders
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Atlas Oncology Partners on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Atlas Oncology Partners’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










